ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Nevada » Rheumatology

Top Rheumatology Prescribers in Nevada

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
NEIL BRAUNSTEIN MD

Rheumatology

5,717

$576K

591
449 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 22%

$101
Average prescription price

Avg: $131

FARHEEN RASOOL M.D

Rheumatology

3,857

$237K

517
402 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 22%

$61
Average prescription price

Avg: $131

KENNETH GRANT M.D.

Rheumatology

3,610

$460K

261
144 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$127
Average prescription price

Avg: $131

H PRUPAS M.D.

Rheumatology

2,400

$512K

292
220 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 22%

$213
Average prescription price

Avg: $131

REX ADAMS M.D.

Rheumatology

2,223

$217K

138
89 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$98
Average prescription price

Avg: $131

STEVEN ATCHESON M.D.

Rheumatology

2,134

$111K

217
187 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $131

JULIE THOMAS M.D.

Rheumatology

1,414

$185K

179
125 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$131
Average prescription price

Avg: $131

MICHAEL CLIFFORD MICHAEL CLIFFORD MD

Rheumatology

1,400

$141K

164
134 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

29%
patients receiving schedule three controlled substances

Avg: 14%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$101
Average prescription price

Avg: $131

JOHN PIXLEY M.D.

Rheumatology

1,214

$347K

129
69 are 65+

19%
patients receiving schedule two controlled substances

Avg: 3%

33%
patients receiving schedule three controlled substances

Avg: 14%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$286
Average prescription price

Avg: $131

CHRISTIANNE YUNG MD

Rheumatology

1,205

$231K

107
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 14%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$191
Average prescription price

Avg: $131

JAY CHUNG MD

Rheumatology

1,186

$191K

136
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$161
Average prescription price

Avg: $131

BAHAR SUMBUL-YUKSEL M.D.

Rheumatology

803

$111K

98
59 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$138
Average prescription price

Avg: $131

NAYA MCKINNON M.D.

Rheumatology

699

$93.1K

108
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 14%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$133
Average prescription price

Avg: $131

SCOTT HARRIS D.O.

Rheumatology

646

$169K

72
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$262
Average prescription price

Avg: $131

ELHAM TAHERIAN MD

Rheumatology

641

$93.1K

104
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 22%

$145
Average prescription price

Avg: $131

MITCHELL FORMAN DO

Rheumatology

554

$98.5K

56
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$178
Average prescription price

Avg: $131

MICHAEL O'HANLAN M.D.

Rheumatology

552

$158K

79
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$286
Average prescription price

Avg: $131

EWA OLECH MD

Rheumatology

550

$63.8K

118
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 22%

$116
Average prescription price

Avg: $131

MICHAEL COLLETTI M.D.

Rheumatology

539

$93.3K

91
76 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$173
Average prescription price

Avg: $131

SUSAN KNOWLES MD

Rheumatology

436

$73.7K

69
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 14%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$169
Average prescription price

Avg: $131

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank